Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease

Cardiovascular disease is the largest cause of morbidity and mortality among patients with chronic kidney disease (CKD) and end-stage kidney disease, with nearly half of all deaths attributed to cardiovascular disease. Hydroxychloroquine (HCQ), an anti-inflammatory drug, has been shown to have multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Ashutosh M., Bose, Chhanda, Karaduta, Oleg K., Apostolov, Eugene O., Kaushal, Gur P., Fahmi, Tariq, Segal, Mark S., Shah, Sudhir V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586379/
https://www.ncbi.nlm.nih.gov/pubmed/26414017
http://dx.doi.org/10.1371/journal.pone.0139226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586379/
https://www.ncbi.nlm.nih.gov/pubmed/26414017
http://dx.doi.org/10.1371/journal.pone.0139226

Ejemplares similares